Navidea Biopharmaceuticals Inc (NYSE American:NAVB)

0.242
Delayed Data
As of 3:46pm ET
 +0.0302 / +14.26%
Today’s Change
0.21
Today|||52-Week Range
0.68
-32.50%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close0.21
Today’s open0.23
Day’s range0.23 - 0.24
Volume367,535
Average volume (3 months)283,265
Market cap$37.0M
Data as of 3:46pm ET, 06/18/2018

Growth & Valuation

Earnings growth (last year)+2.22%
Earnings growth (this year)-86.67%
Earnings growth (next 5 years)--
Revenue growth (last year)-91.76%
P/E ratioNM
Price/Sales32.00
Price/Book3.24

Competitors

 Today’s
change
Today’s
% change
--Innovative Pharmaceu...0.000.00%
FLKSFlex Pharma Inc-0.02-1.54%
CXRXFConcordia Internatio...-0.00-1.43%
PTNPalatin Technologies...-0.06-6.00%
Data as of 3:49pm ET, 06/18/2018

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$1.8M
Annual profit (last year)-$14.2M
Net profit margin-758.21%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mike M. Goldberg
CFO, COO, Secretary &
Treasurer
Jed Andrew Latkin
Corporate headquarters
Dublin, Ohio

Forecasts